Videos

June 12th, 2018

Silence Therapeutics 'in a hot space with few competitors'

Silence Therapeutics' (LON:SLN) Executive Chair, Annalisa Jenkins sat down with Proactive's Andrew Scott to discuss her strategy for taking the drug developer forward and the 'exciting opportunities' in the RNAi space.